List view / Grid view
16 June 2015 | By Victoria White
Marks & Blerk’s latest report highlights the striking difference between research levels into rare diseases, vaccines and antibiotics across the globe...
16 June 2015 | By Victoria White
Agalimmune has licensed KODE Biotech’s Function-Spacer-Lipid (FSL) cell surface membrane modification technology (KODE™ Technology)...
15 June 2015 | By Victoria White
Scientists from Lund University have discovered that expression of ALK1 is significantly associated with the incidence of breast cancer metastasis...
12 June 2015 | By Victoria White
Scientists have created 3D organoid-structures that recapitulate normal breast development and function from single patient-derived cells...
11 June 2015 | By Victoria White
BioNTech has launched MammaTyper, a molecular diagnostic test for breast cancer, for universal use in pathology laboratories in Europe...
11 June 2015 | By Victoria White
The European Society of Clinical Microbiology and Infectious Diseases has launched a new study group: the Forensic and Postmortem Microbiology Study Group...
11 June 2015 | By Victoria White
LDC and Johnson & Johnson Innovation will collaborate to identify and accelerate innovative drug candidates for diseases with high unmet medical needs...
11 June 2015 | By Victoria White
Countering previously held beliefs, researchers have discovered that inhibiting TLR4 may not be a wise treatment strategy in all cancers...
11 June 2015 | By Victoria White
ModiQuest has discovered the cellular mechanism of action of its tACPA for the treatment of rheumatoid arthritis (RA) and other diseases...
10 June 2015 | By Victoria White
A previously unknown link between the immune system and the death of motor neurons in amyotrophic lateral sclerosis has been discovered by scientists...
10 June 2015 | By Drug Target Review
Included in this issue: Drug Discovery, Screening, Hit-to-Lead, Antibodies, Stem Cells, Kinases and much more...
10 June 2015 | By Kenji Schorpp, Kamyar Hadian, Sheraz Gul, Horst Flotow
This Stem Cells In-Depth Focus features articles on stem cell-derived cardiomyocytes, and their use in drug discovery and development, as well as a look at how venom could be used in stem cell differentiation...
10 June 2015 | By Kenji Schorpp, Kamyar Hadian, Sheraz Gul, Horst Flotow
In this Screening In-Depth Focus, high throughput screening is the topic focused on by Kenji Schorpp and Kamyar Hadian, Institute of Molecular Toxicology and Pharmacology, and Sheraz Gul, Fraunhofer Institute for Molecular Biology and Applied Ecology. They discuss the importance of the technique in drug discovery today as well as…
Dementia is a global crisis with 76 million people worldwide expected to be living with the condition by 2030. Current symptomatic treatments provide modest improvements in cognition but disease-modifying therapies for diseases like Alzheimer’s – the most common cause of dementia – do not yet exist.
10 June 2015 | By IntelliCyt Corporation
The immune system plays a vital role in keeping us alive but also participates in many diseases adversely affecting quality of life across the globe. It can be over activated, leading to a variety of inflammation and autoimmune diseases, or suppressed, leading to a vast array of diseases from AIDS…
